Daniel Swift is an experienced professional in market access strategy and launch planning, currently serving as the Director of Market Access Strategy at Insulet Corporation since 2020. Previously, Daniel held positions at Sage Therapeutics, Otsuka Pharmaceutical Companies, Novo Nordisk, Daiichi Sankyo, and Sankyo Pharma, where responsibilities included directing market access marketing, managing digital marketing strategies, and overseeing product management across various therapeutic areas. Daniel's career reflects a strong focus on strategic marketing and launch brand development in the pharmaceutical and biotechnology sectors.
This person is not in any teams
This person is not in any offices